Rabbit Polyclonal Antibody to LARS
货号:
P33863
别名:
Leucine--tRNA ligase, cytoplasmic, Leucyl-tRNA synthetase, LeuRS, LARS, KIAA1352
应用:
WB,IHC
反应种属:
Human
抗体类型:
Primary antibody
Swissprot:
Q9P2J5
规格:
目录价
在线咨询
Description |
---|
LARS, a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. This enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. |
Specification |
|
---|---|
Aliases | Leucine--tRNA ligase, cytoplasmic, Leucyl-tRNA synthetase, LeuRS, LARS, KIAA1352 |
Entrez GeneID | 51520 |
Swissprot | Q9P2J5 |
WB Predicted band size | 134.5kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | This LARS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1118-1145 amino acids from the C-terminal region of human LARS. |
Formulation | Purified antibody in PBS with 0.05% sodium azide,1%BSA and 50% glycerol.prepared by Saturated Ammonium Sulfate (SAS) . |
Application |
|
---|---|
WB | 1/1000 |
IHC | 1/100-1/500 |
Product Image
-
Anti-LARS Antibody (C-term) at 1:1000 dilution + K562 whole cell lysate Lysates/proteins at 20 µg per lane. Secondary Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/10000 dilution. Predicted band size : 134 kDa Blocking/Dilution buffer: 5% NFDM/TBST.
-
Western blot analysis of anti-LARS Antibody (C-term) (Cat.#P33863) in 293 cell line lysates (35ug/lane). LARS(arrow) was detected using the purified Pab.
-
Formalin-fixed and paraffin-embedded human prostata carcinoma tissue reacted with LARS antibody (C-term) (Cat.#P33863), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.